Numerical variation of dark cells in normal and chemically induced hyperplastic epidermis with age of animal and efficiency of tumor promoter.
The percentages of dark keratinocytes was quantitatively assessed in normal epidermis of Sencar mice before and after birth and in adult epidermis after topical application of several compounds of varying promoting efficiency. The percentage of dark keratinocytes reached a maximum at the 19th day of gestation (approximately 40%) and fell abruptly after birth (approximately 3%). Old animals exhibited a very low number of dark basal cells (0.2%). After topical application of the weak promoters resiniferotoxin, anthralin, ethylphenylpropiolate, and 12-deoxyphorbol-13-2,4,6-decatrienoate, the percentage of dark cells in young adult epidermis did not differ markedly from that in control (acetone-treated) specimens. The strong first-stage promoters 4-O-methyl-12-O-tetradecanoylphorbol-13-acetate and calcium ionophore A 23187, as well as the strong complete promoter 12-deoxyphorbol-13-deoxyphorbol-13-decanoate, induced the appearance of large numbers of dark keratinocytes, in a percentage similar to that seen after 12-O-tetradecanoylphorbol-13-acetate application (approximately 20%). The similarities between the dark keratinocytes seen after topical application of 12-O-tetradecanoylphorbol-13-acetate or other strong promoters and the dark cells observed in the fetal epidermis before the onset of the adult type of epidermal keratinization indicate that potent and/or first stage tumor promoters can be identified by their ability to induce cells resembling fetal-type dedifferentiated keratinocytes.
D000287:Administration, Topical; D000367:Age Factors; D000480:Alkynes / Q000494:pharmacology; D000818:Animals; D000875:Anthralin / Q000494:pharmacology; D000001:Calcimycin / Q000494:pharmacology; D002273:Carcinogens / Q000494:pharmacology*; D004817:Epidermis / Q000187:drug effects* / Q000473:pathology; D005260:Female; D005865:Gestational Age; D006965:Hyperplasia / Q000139:chemically induced; D008722:Methods; D051379:Mice; D010703:Phorbol Esters / Q000494:pharmacology; D013936:Thymidine
D000480:Alkynes; D002273:Carcinogens; D010703:Phorbol Esters; C015202:ethylphenylpropiolate; D000001:Calcimycin; D000875:Anthralin; D013936:Thymidine